U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C5H9O3.Na
Molecular Weight 140.1129
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM .ALPHA.-HYDROXYISOVALERATE

SMILES

[Na+].CC(C)C(O)C([O-])=O

InChI

InChIKey=CPGHJLCKGBLVMB-UHFFFAOYSA-M
InChI=1S/C5H10O3.Na/c1-3(2)4(6)5(7)8;/h3-4,6H,1-2H3,(H,7,8);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C5H9O3
Molecular Weight 117.1232
Charge -1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

2-Hydroxyisovaleric acid (also known as 2-Hydroxy-3-methylbutyric acid) is a metabolite found in the urine patients with acidosis and diabetic ketoacidosis. The concentration of this metabolite was also abnormal high in the urine of severely asphyxiated group. In case of maple syrup urine disease, when also the concentration of the 2-hydroxyisovaleric acid was increased in the urine, was made a suggestion, that the early diagnosis and proper treatment can prevent brain damage and improve prognosis.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
The occurrence of 2-hydroxyisovaleric acid in patients with lactic acidosis and ketoacidosis.
1977 Aug 1
Propionyl-CoA carboxylase deficiency: case report, effect of low-protein diet and identification of 3-oxo-2-methylvaleric acid 3-hydroxy-2-methylvaleric acid, and maleic acid in urine.
1981 Apr
Simultaneous determination of plasma levels of alpha-ketoisocaproic acid and leucine and evaluation of alpha-[1-13C]ketoisocaproic acid and [1-13C]leucine enrichment by gas chromatography-mass spectrometry.
1994 Aug 1
Gas chromatography-mass spectrometry with tert.-butyldimethylsilyl derivation: use of the simplified sample preparations and the automated data system to screen for organic acidemias.
2000 Sep 1
Directed biosynthesis of new enniatins.
2001 Oct
Enantiomeric purity determination of malic acid in apple juices by multi-beam circular dichroism detection.
2001 Sep 14
Sebastianines A and B, novel biologically active pyridoacridine alkaloids from the Brazilian ascidian Cystodytes dellechiajei.
2002 Jul 26
Enniatin synthetase is a monomer with extended structure: evidence for an intramolecular reaction mechanism.
2002 Oct
Disturbances of valine metabolism in patients with peroxisomal biogenesis disorders.
2003
Exceptional chiral recognition of racemic carboxylic acids by calix[4]arenes bearing optically pure alpha,beta-amino alcohol groups.
2004 Apr 15
Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks.
2005 May 15
Low-abundance kutznerides from Kutzneria sp. 744.
2006 Dec
Multidimensional chromatographic approach applied to the identification of novel aroma compounds in wine. Identification of ethyl cyclohexanoate, ethyl 2-hydroxy-3-methylbutyrate and ethyl 2-hydroxy-4-methylpentanoate.
2006 Dec 29
Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141.
2006 Mar
Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. II. Structural elucidation.
2007 Feb
Absolute configuration of the creatonotines and callimorphines, two classes of arctiid-specific pyrrolizidine alkaloids.
2007 Jan
Two step derivatization for the analyses of organic, amino acids and glycines on filter paper plasma by GC-MS/SIM.
2007 Mar
Cytotoxic and Antihaptotactic beauvericin analogues from precursor-directed biosynthesis with the insect pathogen Beauveria bassiana ATCC 7159.
2007 Sep
NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats.
2007 Sep 28
Proton HR-MAS NMR spectroscopic characterization of metabolites in various human organ tissues: pancreas, brain and liver from trauma cases.
2008
Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents.
2008 Aug
Biosynthesis of the cyclooligomer depsipeptide beauvericin, a virulence factor of the entomopathogenic fungus Beauveria bassiana.
2008 Sep 22
Biosynthesis of the cyclooligomer depsipeptide bassianolide, an insecticidal virulence factor of Beauveria bassiana.
2009 May
Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain.
2010 Apr 9
NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats.
2010 Nov 1
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Curator's Comment: Urinary 2-hydroxy isovaleric acid, 3-hydroxybutyric acid, 2-keto isovaleric acid, and 2-keto acid also increased. Both the blood amino acid and urine organic acid profiles led to the diagnosis of maple syrup urine disease.
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:09:27 GMT 2023
Edited
by admin
on Sat Dec 16 07:09:27 GMT 2023
Record UNII
4M5OTC1X2O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM .ALPHA.-HYDROXYISOVALERATE
Systematic Name English
BUTANOIC ACID, 2-HYDROXY-3-METHYL-, MONOSODIUM SALT
Systematic Name English
BUTANOIC ACID, 2-HYDROXY-3-METHYL-, SODIUM SALT (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
23684609
Created by admin on Sat Dec 16 07:09:27 GMT 2023 , Edited by admin on Sat Dec 16 07:09:27 GMT 2023
PRIMARY
EPA CompTox
DTXSID10973352
Created by admin on Sat Dec 16 07:09:27 GMT 2023 , Edited by admin on Sat Dec 16 07:09:27 GMT 2023
PRIMARY
ECHA (EC/EINECS)
260-937-8
Created by admin on Sat Dec 16 07:09:27 GMT 2023 , Edited by admin on Sat Dec 16 07:09:27 GMT 2023
PRIMARY
CAS
57768-96-4
Created by admin on Sat Dec 16 07:09:27 GMT 2023 , Edited by admin on Sat Dec 16 07:09:27 GMT 2023
PRIMARY
FDA UNII
4M5OTC1X2O
Created by admin on Sat Dec 16 07:09:27 GMT 2023 , Edited by admin on Sat Dec 16 07:09:27 GMT 2023
PRIMARY